– UK, London – IXICO plc (AIM: IXI), the medical imaging advanced analytics company delivering insights in neuroscience, today announced the appointment of Dr. Dipti Amin to its Board as an Independent Non-Executive Director with immediate effect, bringing significant additional pharmaceutical and CRO experience to the Company.
“We are delighted to welcome Dipti to our Board and look forward to benefitting from her broad and deep experience of both the pharmaceutical and CRO sectors,” said Board Chair, Charles Spicer.
Dr. Amin will also join the Remuneration and Audit Committees.
About Dr. Dipti Amin
Dr. Dipti Amin is an experienced non-executive director and medically trained senior executive with extensive commercial, leadership, and operational experience, in medicine, pharmacology, and the highly regulated healthcare and research sectors. She spent over twenty years of her executive career at IQVIA, occupying senior positions in compliance, drug safety, and medical affairs.
Dr. Amin currently sits on the Boards of the University of Hertfordshire and Lineage Cell Therapeutics, a US-based biotechnology company, having previously sat on the Boards of companies in both the private and public sectors.
About IXICO
IXICO is dedicated to delivering insights into neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Huntington’s disease, Parkinson’s disease, and Alzheimer’s disease. The Company’s purpose is to advance medicine and human health by turning data into clinically meaningful information, providing valuable new insights into neuroscience by supporting pharmaceutical companies across all phases of CNS clinical research. IXICO’s goal is to be a leading advocate of artificial intelligence in medical image analysis.
IXICO has developed and deployed breakthrough data analytics, at scale, through its remote access technology platform, to improve the return on investment in drug development and reduce risk and uncertainty in clinical trials for the Company’s pharmaceutical clients.
SOURCE: https://ixico.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.